• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

显著的甲襞毛细血管缺失和晚期毛细血管镜图像与系统性硬化症相关的肺动脉高压相关。

Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.

机构信息

Rheumatology Unit, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.

Scleroderma Clinic, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.

出版信息

Rheumatology (Oxford). 2024 May 3;63(6):1616-1623. doi: 10.1093/rheumatology/kead445.

DOI:10.1093/rheumatology/kead445
PMID:37624917
Abstract

OBJECTIVE

To evaluate differences in nailfold videocapillaroscopy (NVC) findings between SSc patients with and without a diagnosis of pulmonary arterial hypertension (PAH).

METHODS

One hundred and ten SSc patients were enrolled in this cross-sectional, case-control, multicentre study. Patients were divided into cases (SSc-PAH confirmed by right heart catheterization) and controls (SSc-nonPAH with low probability of PAH). NVC patterns (early, active and late) and morphological parameters (microvascular density, non-specific abnormalities, giant capillaries, micro-haemorrhages, avascular areas) were considered using a semiquantitative scoring system.

RESULTS

SSc-PAH patients showed higher frequencies of late pattern (P < 0.01), non-specific abnormalities (P < 0.01), lower capillary density (P < 0.01), higher avascular areas (P < 0.01) and a higher mean NVC score (P < 0.01). Contrarily, the early/active pattern (P < 0.01) and a higher rate of micro-haemorrhages (P = 0.04) were more frequent in non-PAH patients. By a multivariate analysis, SSc-PAH patients, compared with non-PAH, had more non-specific abnormalities [27/55, 49.1% vs 10/55, 18.2%; adjusted odd ratio (OR) 16.89; 95% CI: 3.06, 93.16], a lower capillary density (grade 3, 20/55, 36.4% vs 5/55, 9.1%; adjusted OR 38.33; 95% CI: 2.34, 367.80) and avascular areas (18/55, 32.7% vs 10/55, 18.2%; adjusted OR 16.90; 95% CI: 2.64, 44.35). A correlation was found between the mean pulmonary arterial pressure and avascular areas (P < 0.01), capillary density (P < 0.01) and non-specific abnormalities (P < 0.01). A clinical model including the NVC variables may be able to predict a diagnosis of PAH.

CONCLUSION

Our results indicate that the distinctive peripheral microcirculatory injury of SSc, i.e. capillary loss and morphological abnormalities, appear more severe and pronounced in patients with SSc-PAH.

摘要

目的

评估有和无肺动脉高压(PAH)诊断的系统性硬化症(SSc)患者的甲襞毛细血管镜(NVC)检查结果差异。

方法

本研究为一项横断面、病例对照、多中心研究,共纳入 110 例 SSc 患者。患者分为病例组(经右心导管检查确诊的 SSc-PAH)和对照组(SSc-非 PAH 且 PAH 可能性低)。使用半定量评分系统评估 NVC 模式(早期、活跃和晚期)和形态学参数(微血管密度、非特异性异常、巨毛细血管、微出血、无血管区)。

结果

SSc-PAH 患者晚期模式(P<0.01)、非特异性异常(P<0.01)、毛细血管密度较低(P<0.01)、无血管区较高(P<0.01)和平均 NVC 评分较高(P<0.01)的发生率更高。相反,非 PAH 患者中早期/活跃模式(P<0.01)和较高的微出血发生率(P=0.04)更为常见。多变量分析显示,与非 PAH 患者相比,SSc-PAH 患者的非特异性异常更多[27/55,49.1%比 10/55,18.2%;调整后比值比(OR)16.89;95%置信区间:3.06,93.16],毛细血管密度较低(3 级,20/55,36.4%比 5/55,9.1%;调整后 OR 38.33;95%置信区间:2.34,367.80)和无血管区较大(18/55,32.7%比 10/55,18.2%;调整后 OR 16.90;95%置信区间:2.64,44.35)。平均肺动脉压与无血管区(P<0.01)、毛细血管密度(P<0.01)和非特异性异常(P<0.01)呈正相关。包含 NVC 变量的临床模型可能能够预测 PAH 诊断。

结论

我们的结果表明,SSc 患者外周微循环损伤更为严重,即毛细血管丧失和形态异常,在 SSc-PAH 患者中更为明显和严重。

相似文献

1
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.显著的甲襞毛细血管缺失和晚期毛细血管镜图像与系统性硬化症相关的肺动脉高压相关。
Rheumatology (Oxford). 2024 May 3;63(6):1616-1623. doi: 10.1093/rheumatology/kead445.
2
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.特发性肺动脉高压和系统性硬皮病相关肺动脉高压患者的甲襞毛细血管变化。
Microvasc Res. 2017 Nov;114:46-51. doi: 10.1016/j.mvr.2017.06.005. Epub 2017 Jun 12.
3
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study.系统性硬皮病合并与不合并肺动脉高压患者的甲襞毛细血管研究。
Rheumatology (Oxford). 2013 Aug;52(8):1525-8. doi: 10.1093/rheumatology/ket168. Epub 2013 May 13.
4
Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.甲襞毛细血管密度与系统性硬化症中肺动脉高压的存在及严重程度相关。
Ann Rheum Dis. 2009 Feb;68(2):191-5. doi: 10.1136/ard.2007.087353. Epub 2008 Mar 28.
5
Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases.结缔组织病相关肺动脉高压患者的甲襞微循环视频镜检变化。
Rheumatol Int. 2021 Jul;41(7):1289-1298. doi: 10.1007/s00296-021-04839-x. Epub 2021 May 12.
6
Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.甲褶毛细血管镜异常与混合性结缔组织病和系统性硬化症患者的肺动脉高压。
Eur Rev Med Pharmacol Sci. 2024 Feb;28(4):1314-1326. doi: 10.26355/eurrev_202402_35453.
7
Nailfold Videocapillaroscopy in Systemic Sclerosis-related Pulmonary Arterial Hypertension: A Systematic Literature Review.甲襞毛细血管显微镜检查在系统性硬化症相关肺动脉高压中的应用:系统文献回顾。
J Rheumatol. 2020 Jun 1;47(6):888-895. doi: 10.3899/jrheum.190296. Epub 2019 Aug 15.
8
Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压患者的外周微血管功能与心血管磁共振上的心脏受累有关。
Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):708-717. doi: 10.1093/ehjci/jeae001.
9
Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?肺动脉高压和慢性血栓栓塞性肺动脉高压患者甲襞毛细血管密度降低:临床结局的生物标志物?
Sci Rep. 2024 Aug 22;14(1):19467. doi: 10.1038/s41598-024-69017-y.
10
Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study.系统性硬化症相关肺动脉高压的外周微血管病变改变:一项多中心观察性研究的数据
Front Cardiovasc Med. 2022 Jul 11;9:924899. doi: 10.3389/fcvm.2022.924899. eCollection 2022.

引用本文的文献

1
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale).系统性硬化症患者的2型糖尿病:来自意大利临床与实验风湿病研究组(GIRRCS)一项观察性多中心研究的见解
Arthritis Res Ther. 2025 Jul 28;27(1):157. doi: 10.1186/s13075-025-03619-3.
2
Sex Bias in Systemic Sclerosis: from Clinical to Immunological Differences.系统性硬化症中的性别偏见:从临床差异到免疫差异
Clin Rev Allergy Immunol. 2025 May 27;68(1):51. doi: 10.1007/s12016-025-09062-1.
3
Lasso-derived model for early prediction of systemic sclerosis based on vasculopathy assessment: a population-based cohort study.
基于血管病变评估的系统性硬化症早期预测套索衍生模型:一项基于人群的队列研究
Rheumatol Int. 2025 Mar 22;45(4):78. doi: 10.1007/s00296-025-05835-1.
4
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.TAPSE/sPAP比值对系统性硬化症合并肺动脉高压患者心血管事件和死亡率的预测作用。
Front Cardiovasc Med. 2024 Oct 14;11:1430903. doi: 10.3389/fcvm.2024.1430903. eCollection 2024.
5
Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis.低一氧化碳弥散能力、患者报告的指标以及甲襞毛细血管密度降低与系统性硬化症中的间质性肺疾病相关。
J Pers Med. 2024 Jun 14;14(6):635. doi: 10.3390/jpm14060635.